Everand Logo

Welcome to Everand!

  • NPR

    US Vaccine Candidate Heads To Widespread Testing In People

    A COVID-19 vaccine candidate developed by the US company Moderna and the National Institutes of Health starts its final phase of testing today. It's one of a handful of candidates to reach this stage.
    by Joe Palca Jul 27, 2020 1 minute
    Biotech company Moderna, headquartered in Cambridge, Massachusetts, announced today that it is beginning Phase 3 trials of its COVID-19 vaccine. It will enroll up to 30,000 volunteers.

    The COVID-19 vaccine candidate made by the U.S. biotech company Moderna, Inc. and developed in collaboration with the National Institutes of Health starts its final phase of testing today.

    This phase is called Phase 3 efficacy testing and it is designed to know who is getting what.

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR2 min readCrime & Violence
    After Two Boeing 737 Max Crashes, Families Are Still Seeking Answers From DOJ
    More than five years after two 737 MAX crashes killed 346 people, families of the victims are still pushing the Justice Department to hold Boeing accountable. They're frustrated by the response.
    NPR2 min readInternational Relations
    PEN America Cancels Awards Ceremony After Writers Protest
    PEN America has cancelled its annual Literary Awards ceremony after nearly half of the authors nominated withdrew in protest over the organization's response to the Israeli-Hamas war in Gaza.
    NPR4 min readInternational Relations
    An American Hostage Is Seen Alive For The First Time Since Oct. 7 In A Hamas Video
    Hersh Goldberg-Polin, who turned 24 last month while in captivity, has spent more than 200 days in captivity. His left arm was partially blown off by a grenade during the Hamas-led attack on Oct. 7.

    Related